azacitidine,venetoclax
abbvie,roche
['leukemia', 'venetoclax', 'myeloid', 'toci', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'azacitidine,(-oral azaci),(-azacitidine oral)', 'aza ', 'leusm', 'viale-a']
#ash22 #leusm gangat: outcomes in aml after failure of frontline hma/ven. at mayo median os with hma/ven 8.5mos (less than viale-a). 71/103 treated 2018-20220 relapsed or were refractory. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)